Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

759 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity.
Frasca F, Scordio M, Santinelli L, Gabriele L, Gandini O, Criniti A, Pierangeli A, Angeloni A, Mastroianni CM, d'Ettorre G, Viscidi RP, Antonelli G, Scagnolari C. Frasca F, et al. Among authors: antonelli g. Eur J Immunol. 2022 Jul;52(7):1120-1128. doi: 10.1002/eji.202249824. Epub 2022 Apr 28. Eur J Immunol. 2022. PMID: 35419822 Free PMC article.
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations.
Scagnolari C, Bellomi F, Turriziani O, Bagnato F, Tomassini V, Lavolpe V, Ruggieri M, Bruschi F, Meucci G, Dicuonzo G, Antonelli G. Scagnolari C, et al. Among authors: antonelli g. J Interferon Cytokine Res. 2002 Feb;22(2):207-13. doi: 10.1089/107999002753536176. J Interferon Cytokine Res. 2002. PMID: 11911803
Impaired 2',3'-dideoxy-3'-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11.
Turriziani O, Schuetz JD, Focher F, Scagnolari C, Sampath J, Adachi M, Bambacioni F, Riva E, Antonelli G. Turriziani O, et al. Among authors: antonelli g. Biochem J. 2002 Nov 15;368(Pt 1):325-32. doi: 10.1042/BJ20020494. Biochem J. 2002. PMID: 12133003 Free PMC article.
Proteolytic balance in patients with multiple sclerosis during interferon treatment.
Giannelli G, De Marzo A, Scagnolari C, Bergamini C, Fransvea E, Bagnato F, Bellomi F, Millefiorini E, Gasperini C, Antonaci S, Antonelli G. Giannelli G, et al. Among authors: antonelli g. J Interferon Cytokine Res. 2002 Jun;22(6):689-92. doi: 10.1089/10799900260100187. J Interferon Cytokine Res. 2002. PMID: 12162880
Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis.
Monzani F, Meucci G, Caraccio N, Saviozzi M, Casolaro A, Moscato G, Lombardo F, Mosti S, Scagnolari C, Bruschi F, Antonelli G, Ferrannini E, Murri L. Monzani F, et al. Among authors: antonelli g. J Interferon Cytokine Res. 2002 Jul;22(7):773-81. doi: 10.1089/107999002320271369. J Interferon Cytokine Res. 2002. PMID: 12184915
Treatment of SARS with human interferons.
Antonelli G, Scagnolari C, Vicenzi E, Clementi M. Antonelli G, et al. Lancet. 2003 Oct 4;362(9390):1158; author reply 1158-9. doi: 10.1016/S0140-6736(03)14482-0. Lancet. 2003. PMID: 14550714 Free PMC article. No abstract available.
759 results